CDC test directory updates

The CDC has revised its infectious disease testing procedures, introducing new test orders and discontinuing others, amid ongoing staffing shortages that threaten laboratory capabilities.
April 3, 2026
2 min read

The Centers for Disease Control and Prevention’s (CDC) infectious diseases laboratories accept specimens from state public health laboratories and other federal agencies for analysis. Effective March 30, 2026, the CDC updated several test orders in its directory according to an update on its website.

New test orders:

  • Brucella Species Antimicrobial Susceptibility Testing – CLIA
  • New World Hantavirus Testing – Non-CLIA

Deleted test orders (no longer performed at CDC):

  • Filariasis Serology – CLIA
  • Toxocariasis Serology – CLIA

Numerous tests have been temporarily paused (see examples below). The reason given for some is that commercial diagnostic testing is available.

  • Adenovirus Molecular Detection – CLIA
  • Poxvirus Molecular Detection – CLIA
  • Poxvirus Serology – CLIA
  • Rabies Antibody Titer (Human) – CLIA
  • Rabies Antemortem Human Testing – CLIA

According to the New York Times, “layoffs, hiring freezes and resignations have shrunk the number of qualified scientists who can assist state labs. The CDC’s rabies and pox virus teams have lost many of their members. By July, the rabies team will be down to just one person with the clinical expertise to advise state and local officials, and the pox virus team will have none,” according to an anonymous source.

About the Author

Christina Wichmann

Editor-in-Chief

Editor in Chief, Medical Laboratory Observer | Endeavor B2B

Sign up for our eNewsletters
Get the latest news and updates